Tadalafil — the generic for Cialis — is the long-acting member of the PDE5 inhibitor family. It works through the same mechanism as sildenafil, but the way it fits into real life is very different because its effects can last well over a day from a single dose. [1]
The mechanism in plain English
When you're aroused, your nerves release nitric oxide, which boosts a messenger called cGMP. cGMP relaxes the smooth muscle in penile blood vessels so blood can fill in. An enzyme called PDE5 normally breaks cGMP down. Tadalafil blocks PDE5, so cGMP sticks around longer and erections become firmer and easier to sustain. You still need sexual stimulation — tadalafil only sets the stage. [2]
What makes tadalafil different
- Half-life of about 17.5 hours — effects can last up to 36 hours per dose.
- Food and alcohol don't meaningfully delay absorption.
- Comes in on-demand strengths (10 mg, 20 mg) and daily low-dose strengths (2.5 mg, 5 mg).
- FDA-approved for both ED and benign prostatic hyperplasia (BPH).
On-demand vs daily dosing
On-demand tadalafil (10–20 mg) is taken at least 30 minutes before sex. Daily tadalafil (2.5–5 mg) is taken every morning so your body always has a therapeutic level on board — meaning sex doesn't need to be planned around a pill. In clinic, daily dosing is what most men switch to once they realize how much pressure it takes off intimacy. [3]
What to expect
Roughly 70–80% of men respond well to tadalafil. With on-demand dosing, you typically feel an effect within 30–45 minutes, with a wide 36-hour window. With daily dosing, the effect builds over the first 5–7 days and becomes more reliable from there. [1]
Side effects
The most common ones are headache, flushing, indigestion, and — uniquely for tadalafil — mild back or muscle aches that show up 12–24 hours after dosing. Most resolve as your body adjusts. If they don't, a dose reduction usually fixes it.
When tadalafil isn't safe
Never combine tadalafil with nitrates or guanylate cyclase stimulators (like riociguat). Tell your clinician about all alpha-blockers and blood pressure medications. Severe heart, liver, or kidney disease may rule it out, which is why we screen carefully before prescribing.
The bottom line
If spontaneity matters to you, tadalafil — especially daily low-dose — is hard to beat. Try it for 4–6 weeks, message us with how it's going, and we'll fine-tune the dose until it's the right fit.
Available across Florida
Reset My Vitality is a Florida-licensed telehealth practice. The treatments covered in this guide are available to patients statewide, with medication shipped directly to your door. Explore the program for your city:
- Men's Health in Miami, FL
- Men's Health in Miami Beach, FL
- Men's Health in Fort Lauderdale, FL
- Men's Health in West Palm Beach, FL
- Men's Health in Boca Raton, FL
- Men's Health in Orlando, FL
- Men's Health in Tampa, FL
- Men's Health in Jacksonville, FL
- Men's Health in Naples, FL
Key Clinical Studies
A short, responsible summary of recent peer-reviewed research relevant to this topic. This is for education only, not medical advice.
BMJ Open · 2021
Key finding: PDE5 inhibitors including tadalafil consistently improved erectile function across systematic reviews and meta-analyses.
Why it matters: Directly supports tadalafil as first-line oral therapy for erectile dysfunction.
View studyAssociations between PDE5 inhibitors and vascular function
Systematic Reviews · 2025
Key finding: RCT meta-analysis confirmed PDE5 inhibitors improve vascular function, consistent with tadalafil's long-acting profile.
Why it matters: Explains tadalafil's 36-hour window and supports its long-term cardiovascular safety profile.
View studyScientific References
Peer-reviewed studies and reviews cited in this article.
- [1]Huang Y, et al. Effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews and meta-analyses. BMJ Open. 2021;11(8):e047396. View study
- [2]Zhang Y, et al. Associations between phosphodiesterase type 5 inhibitors and vascular function: a systematic review and meta-analysis on randomized-controlled trials. Systematic Reviews. 2025. View study
- [3]Pyrgidis N, et al. Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis. JAMA Network Open. 2021;4(2):e2036337. View study
